Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

This review discusses the immunological effects and systemic actions of S1PR modulators, and their use in multiple sclerosis and other conditions, including for example acute renal transplant rejection, stroke, SLE, Rett syndrome, brain tumour, psoriasis and schizophrenia.

The Lancet